Breast Cancer

Suppressing MAFK pathway in tumor cells may slow spread of aggressive breast cancer.

Low-dose aspirin may help women reduce their risk of developing breast cancer, a new study published in Breast Cancer Research has suggested.

A patient discusses the struggle of receiving treatment for triple negative breast cancer in a rural community.

Major life events regarding close personal relationships may play a role in mortality.

The substantial adverse impact of second cancers may explain the lack of improvement in young adult survival compared with older adults.

Protein determines whether breast cancer cells become resistant to tamoxifen.

Protein determines whether breast cancer cells become resistant to tamoxifen.

Employing proteogenomics helps identifies therapeutic targets in breast cancer.

An artificial intelligence platform detected 92.4% of breast cancer tumors.

Exposure to BPA observed to increase signaling that caused cancer growth.

Top news of the day from across the health care landscape.

German shepherds undergo training to detect breast cancer through smell.

Top news of the week in oncology and cancer drug development.

Overexpression of protein reveals why breast cancer spreads quickly.

Breast cancer cells may use reelin protein to evade the immune system.

Study identifies 2 immune system molecules that may play a key role in drug-resistance.

The cytokines interleukin 1 beta (IL1β) and tumor necrosis factor alpha (TNFα) help the spread of drug-resistant cancer.

More than 3000 patients with breast cancer have received radiation with the Xoft System.

Epalrestat could prevent metastasis in patients with basal-like triple-negative breast cancer.

High consumption of isoflavones reduced all-cause mortality in patients with breast cancer by 21%.

Repurposed drugs may provide new therapies for cancer.

Isoflavone supplements may influence outcomes among patients with breast cancer.

Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.

Next-generation antibody treatments effectively deliver cytotoxic drugs to tumors.

Top news of the week in oncology and cancer drug development.